Abstract |
Recently, long noncoding RNAs (lncRNAs) have been applied as biomarkers for melanoma patients. In this systematic review and meta-analysis, we investigated the diagnostic and prognostic value of lncRNAs. We used the keywords ' lncRNA' and ' melanoma' to search databases for studies published before June 14th, 2023. The specificity, sensitivity and AUC were utilized to assess diagnostic accuracy and the prognostic value was assessed using overall survival, progression-free survival and disease-free survival hazard ratios. After screening 1191 articles, we included seven studies in the diagnostic evaluation section and 17 studies in the prognosis evaluation section. The Reitsma bivariate model estimated a cumulative sensitivity of 0.724 (95% CI: 0.659-0.781, p < 0.001) and specificity of 0.812 (95% CI: 0.752-0.859, p < 0.001). The pooled AUC was 0.780 (95% CI: 0.749-0.811, p < 0.0001). The HR for overall survival was 2.723 (95% CI: 2.259-3.283, p < 0.0001). Two studies reported an HR for overall survival less than one, with an HR of 0.348 (95% CI: 0.200-0.607, p < 0.0002). The HR for progression-free survival was 2.913 (95% CI: 2.050-4.138, p < 0.0001). Four studies reported an HR less than one, with an HR of 0.457 (95% CI: 0.256-0.817). The HR for disease-free survival was 2.760 (95% CI: 2.009-3.792, p < 0.0001). In conclusion, the expression of lncRNAs in melanoma patients affects survival and prognosis. LncRNAs can also be employed as diagnostic biomarkers.
|
Authors | Mahdi Masrour, Shaghayegh Khanmohammadi, Parisa Fallahtafti, Seyedeh Melika Hashemi, Nima Rezaei |
Journal | Journal of cellular and molecular medicine
(J Cell Mol Med)
Vol. 28
Issue 3
Pg. e18109
(Feb 2024)
ISSN: 1582-4934 [Electronic] England |
PMID | 38193829
(Publication Type: Meta-Analysis, Systematic Review, Journal Article, Review)
|
Copyright | © 2024 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd. |
Chemical References |
- RNA, Long Noncoding
- Biomarkers, Tumor
|
Topics |
- Humans
- RNA, Long Noncoding
(genetics)
- Melanoma
- Prognosis
- Biomarkers, Tumor
(genetics)
- Proportional Hazards Models
|